c-Myc, Snai1, and Id1, but not Tcf4 and Id2, were found to be highly expressed in the colon cancer cell-derived CM-treated group compared to the control (Ctrl) group (Fig. 1b, c). Here, MYC is linked to malignant colon neoplasm.